Receive Windhover's unique market insight fast with our free alert
service 'Windhover's Update', including the latest abstracts
and summaries from:
• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight
Sign up
now
|
|
|
|
|
Connecticut Office
10 Hoyt Street
Norwalk, CT 06851
Tel: (203) 838-4401
Fax: (203) 838-3214 |
New Jersey Office
685 Route 202/206
Bridgewater NJ 08807
Toll Free: (800) 332-2181
Tel: (908) 547-2159
Fax: (908) 547-2165
Email Us
|
Maryland Office
5635 Fishers Lane
Rockville MD 20852
Tel: (800) 332-2181
Fax: (240) 221-4400
Email Us -
Website |
California Office
1 Technology Drive
Building J, Suite 703
Irvine CA 92618
Tel: (949) 453-0071
Fax: (949) 453-0072
Email Us
- Website |
|
|
Customer Care
Toll Free: (800) 332-2181
Tel: (908) 547-2159
Fax: (908) 547-2165
Email Us
|
Conferences
Tel: (203) 838-4401 ext. 113, 119
Fax: (203) 838-3214
Email Us |
Reprints
Tel: (203) 838-4401 ext. 124
Fax: (203) 838-3214
Email Us |
Editorial
Tel: (203) 838-4401
Fax: (203) 838-3214
Email Us |
Advertising & Sponsorships
Ken May
Director, Commercial Sales
Tel: (914) 332-1419
Mobile: (914) 356-5107
Email Us |
Strategic Transactions & Inteleos
Sales & Client Support
Tel: (203) 838-4401 ext. 104
Email Us |
Technical Support / IT
Tel: (203) 838-4401 ext. 236
Fax: (203) 838-3214
Email Us
|
|
|
 |
|
 |
|
|
| |
 |
Biopharma Trends: Nowhere To Go But Up
Biopharmaceutical trends in 2008 were fundamentally altered by the global financial crisis. And 2009's events were similarly impacted by the ongoing recovery. . . [MORE] (IN VIVO)
The A-List: 2009's Trend-Shaping Series A Financings
New company creation slipped significantly in 2009 as venture capitalists conserved capital and supported existing portfolio companies. . . [MORE] (Start-Up)
Stent Market Doldrums Push Interest Elsewhere
The new realities of the drug-eluting stent market are evident in recent sales results from the big competitors, driving many of them to branch into other higher growth areas. . . [MORE] (Medtech Insight)
The Future of Pharma: The Scale to Fail
The pharmaceutical sector saw a wave of major consolidation in 2009. There are a number of lessons to be learned from the M&A activity that can be applied to the New Year, including the increasing need to get bigger in order to absorb the R&D misses. . . [MORE] (The RPM Report)
Read
more from the latest:
IN VIVO,
Start-Up,
The RPM Report,
Medtech Insight, "The Pink Sheet",
"The Pink Sheet" DAILY,
"The Rose Sheet",
"The Tan Sheet",
PharmAsia News,
Pharmaceutical Approvals Monthly, and
"The Gray Sheet".
|
|
|
|
| |
|
|
|
|
|
